People: CellaVision AB (CEVI.ST)
Mr. Christer Fahraeus has been Member of the Board of Directors of CellaVision AB since June 1998. Previously he was Chief Executive Officer and Member of the Board of the Company. He joined the Board in 1994. He is founder of the Company. His former positions include Chief Executive Officer of Anoto Group AB and Agellis Group AB. He is founder of Anoto Group AB, Precise Biometrics AB, Agellis Group AB and Flatfrog Laboratories AB, among others. He is Chief Executive Officer of EQL Pharma AB and Chairman of the Board of Longboat laboratoriesof, Respiratorius AB and Flatfrog Laboratories AB. He is also Member of the Boards of EQL Pharma AB, Lunds universitets innovationssystem AB, Faro Capital AB and Reccan AB. Mr. Fahraeus holds a Master of Science degree in Bioengineering and a Bachelor of Science degree in Mathematics from Lunds Universitet. He also holds a honoris causa Doctorate in Philosophy from Lunds Universitet.
|Total Annual Compensation, SEK||200,000|
|Restricted Stock Award, SEK||--|
|Long-Term Incentive Plans, SEK||--|
|All Other, SEK||--|
|Fiscal Year Total, SEK||200,000|